IGF-II R

IGF-II R 詳細

英語名Insulin-like growth factor II receptor市販薬剤の数1
治験薬の数0ターゲットの別称Insulin-like growth factor 2 receptor,IGF-II receptor,CD222,Insulin Like Growth Factor 2 Receptor,M6P/IGF2R,M6P/IGF2 receptor,CI Man-6-P receptor,Insulin-like growth factor II receptor,IGF2R,300 KDa Mannose 6-Phosphate Receptor,MPR 300,MPRI,Cation-Independent Mannose-6-Phosphate Receptor,Cation-Independent Mannose-6 Phosphate Receptor,CD222 Antigen,CI-M6PR,MPR300,CI-MPR,CIMPR,M6P-R,MPR1,M6PR,Receptor, IGF Type 2
研究&開発段階Approved
英語名Insulin-like growth factor II receptor
ターゲットの別称Insulin-like growth factor 2 receptor,IGF-II receptor,CD222,Insulin Like Growth Factor 2 Receptor,M6P/IGF2R,M6P/IGF2 receptor,CI Man-6-P receptor,Insulin-like growth factor II receptor,IGF2R,300 KDa Mannose 6-Phosphate Receptor,MPR 300,MPRI,Cation-Independent Mannose-6-Phosphate Receptor,Cation-Independent Mannose-6 Phosphate Receptor,CD222 Antigen,CI-M6PR,MPR300,CI-MPR,CIMPR,M6P-R,MPR1,M6PR,Receptor, IGF Type 2
市販薬剤の数1
治験薬の数0
研究&開発段階Approved

IGF-II R 製品リスト

  • 属性

    Protein (2)

  • 製品ライブラリ

    オンライン (2)

  • Human (2)

  • タグ

    His Tag (2)

  • マーカー

    Unconjugated (2)

製品番号発現システム製品説明タンパク質の構造純度特性
IGR-H52H4
Human
HEK293
Human IGF-II R (43-1365) Protein, His Tag (MALS verified)
IGR-H53H3
Human
CHO
Human IGF-II R Protein, His Tag (MALS verified)
総数量2
  • 1

IGF-II Rバックグランド

IGF2R, also known as the cation-independent mannose-6-phosphate receptor, is found ubiquitously in human tissues with a truncated soluble form of the receptor present in the circulation. Full-length, 300-kDa, IGF2R comprises a large N-terminal extracellular region of 15 homologous domains, a single membrane-spanning region and a small cytoplasmic tail. In addition to IGF-II binding, major IGF2R functions include sorting newly synthesized lysosomal enzymes and endocytosis of extracellular lysosomal enzymes. To perform these disparate functions, the extracellular region contains binding sites for IGF-II and phosphomannosyl residues

IGF-II R分子の別称

Cation-independent mannose-6-phosphate receptor,CI Man-6-P receptor,CI-MPR,M6PR,300 kDa mannose 6-phosphate receptor (MPR 300),Insulin-like growth factor 2 receptor,Insulin-like growth factor II receptor (IGF-II receptor),M6P/IGF2 receptor (M6P/IGF2R),CD2

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Avalglucosidase alfaneoGAA; GZ-402666; Neo-rhGAA; NeoGAAApprovedGenzyme CorpNexviazyme, Nexviadyme, 耐而赞United StatesGlycogen Storage Disease Type IIGenzyme Corp2021-08-06Glycogen Storage Disease Type II
詳細
  • 詳細
  • 製品リスト
  • 市販薬剤に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8